NCT05522387 2026-02-27
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Inmune Bio, Inc.
Phase 2 Terminated
Inmune Bio, Inc.
Medical College of Wisconsin
Atara Biotherapeutics
National Institutes of Health Clinical Center (CC)
Indiana University
Swedish Orphan Biovitrum